US 10925969
Anti-BCMA polypeptides and proteins
granted A61KA61K2039/505A61K39/00
Quick answer
US patent 10925969 (Anti-BCMA polypeptides and proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2039/505, A61K39/00, A61K47/6415, A61K47/6425